Asia Pacific Dermal Fillers Market Forecast to 2031 - Regional Analysis - by Product, Material (Calcium Hydroxylapatite, Hyaluronic Acid, Collagen, Poly-L-Lactic Acid, Polmethylmethacrylate, Fat Fillers, and Others), Application, and End User

List of Tables

The Asia Pacific dermal fillers market was valued at US$ 854.98 million in 2023 and is expected to reach US$ 1,757.83 million by 2031; it is estimated to register a CAGR of 9.4% from 2023 to 2031.

Increasing Disposable Incomes and Expanding Middle-Class Population Drive Asia Pacific Dermal Fillers Market

As per the European Union, the middle-class population category will have more than 5.3 billion people globally by 2030. Most of this growth is likely to persist in Asia. By 2030, China and India are expected to represent approximately 65% of the global middle-class population. The expanding middle class is expected to boost economic development as well as change consumer behavior and consumption patterns. With more disposable income, changes in technology, and better after-care, the attitude toward cosmetic and skin-related conditions has changed, and the adoption of treatment procedures and home-based medical devices has increased. Furthermore, multinational corporations in the beauty and skincare industry explicitly target the massive Indian population and growing middle-class individuals due to the positive response received for their products. Thus, the increase in disposable income will likely fuel the adoption rate of beauty devices, providing lucrative opportunities for market growth.

Asia Pacific Dermal Fillers Market Overview

The Asia Pacific dermal fillers market is expected to grow at a high CAGR from 2023 to 2031. The market in China and Japan is expected to grow at a fast pace due to the increasing popularity of dermal fillers and growing medical tourism. In China, dermal fillers are gaining significant traction in various public and private hospitals. It is further increased due to higher disposable income and concerns related to looks. Moreover, India is emerging as one of the growing markets for dermal fillers owing to the aging population, increasing income, and affordability.

Asia Pacific Dermal Fillers Market Revenue and Forecast to 2031 (US$ Million)

Asia Pacific Dermal Fillers Market Segmentation

The Asia Pacific Dermal Fillers Market is categorized into product, material, application, end user, and country.

Based on product, the Asia Pacific Dermal Fillers Market is bifurcated biodegradable and nonbiodegradable. The biodegradable segment held a larger market share in 2023.

In terms of material, the Asia Pacific Dermal Fillers Market is categorized calcium hydroxylapatite, hyaluronic acid, collagen, poly-l-lactic acid, polmethylmethacrylate (PMMA), fat fillers, and others. The hyaluronic acid segment held the largest market share in 2023.

By application, the Asia Pacific Dermal Fillers Market is segmented into facial line correction treatment, lip enhancement, face lift, scar treatment, and others. The lip enhancement segment held the largest market share in 2023.

By end user, the Asia Pacific Dermal Fillers Market is segmented into multispecialty hospitals, dermatology clinics, ambulatory surgical centers, and others. The dermatology clinics segment held the largest market share in 2023.

By country, the Asia Pacific Dermal Fillers Market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific Dermal Fillers Market share in 2023.

AbbVie Inc; BIOPLUS CO., LTD.; BIOXIS pharmaceuticals; Galderma SA; Merz Pharma GmbH & Co KGaA; Prollenium Medical Technologies; Sinclair Pharma Ltd; Suneva Medical; and TEOXANE LABORATORIES are some of the leading companies operating in the Asia Pacific Dermal Fillers Market.

Product Code: TIPRE00025324

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Dermal Fillers Market - Key Market Dynamics

4.1 Market Drivers
- 4.1.1 Increasing Preference for Minimally Invasive Procedures
- 4.1.2 Rising Attraction of Consumers Toward Beauty and Wellness
4.2 Market Restraints
- 4.2.1 High Cost of Dermal Filler Procedures
4.3 Market Opportunities
- 4.3.1 Increasing Disposable Incomes and Expanding Middle-Class Population
- 4.3.2 Growing Medical Tourism for Cosmetic Procedures
4.4 Future Trends
- 4.4.1 Growing Adoption of Combination Therapies
4.5 Impact of Drivers and Restraints:

5. Dermal Fillers Market - Asia Pacific Analysis

5.1 Asia Pacific Dermal Fillers Market Revenue (US$ Million), 2021-2031
5.2 Asia Pacific Dermal Fillers Market Forecast Analysis

6. Asia Pacific Dermal Fillers Market Analysis - by Product

6.1 Biodegradable
- 6.1.1 Overview
- 6.1.2 Biodegradable: Asia Pacific Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
6.2 Non-biodegradable
- 6.2.1 Overview
- 6.2.2 Non-biodegradable: Asia Pacific Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)

7. Asia Pacific Dermal Fillers Market Analysis - by Material

7.1 Calcium Hydroxylapatite
- 7.1.1 Overview
- 7.1.2 Calcium Hydroxylapatite: Asia Pacific Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Hyaluronic Acid
- 7.2.1 Overview
- 7.2.2 Hyaluronic Acid: Asia Pacific Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Collagen
- 7.3.1 Overview
- 7.3.2 Collagen: Asia Pacific Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Poly-L-Lactic Acid
- 7.4.1 Overview
- 7.4.2 Poly-L-Lactic Acid: Asia Pacific Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Polmethylmethacrylate (PMMA)
- 7.5.1 Overview
- 7.5.2 Polmethylmethacrylate (PMMA): Asia Pacific Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
7.6 Fat Fillers
- 7.6.1 Overview
- 7.6.2 Fat Fillers: Asia Pacific Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
7.7 Others
- 7.7.1 Overview
- 7.7.2 Others: Asia Pacific Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Dermal Fillers Market Analysis - by Application

8.1 Facial Line Correction Treatment
- 8.1.1 Overview
- 8.1.2 Facial Line Correction Treatment: Asia Pacific Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Lip Enhancement
- 8.2.1 Overview
- 8.2.2 Lip Enhancement: Asia Pacific Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Face Lift
- 8.3.1 Overview
- 8.3.2 Face Lift: Asia Pacific Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Scar Treatment
- 8.4.1 Overview
- 8.4.2 Scar Treatment: Asia Pacific Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: Asia Pacific Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)

9. Asia Pacific Dermal Fillers Market Analysis - by End User

9.1 Multispecialty Hospitals
- 9.1.1 Overview
- 9.1.2 Multispecialty Hospitals: Asia Pacific Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Dermatology Clinics
- 9.2.1 Overview
- 9.2.2 Dermatology Clinics: Asia Pacific Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
9.3 Ambulatory Surgical Centers
- 9.3.1 Overview
- 9.3.2 Ambulatory Surgical Centers: Asia Pacific Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Others
- 9.4.1 Overview
- 9.4.2 Others: Asia Pacific Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)

10. Asia Pacific Dermal Fillers Market - Country Analysis

10.1 Asia Pacific
- 10.1.1 Asia Pacific Dermal Fillers Market Breakdown, by Key Countries, 2023 and 2031 (%)
  - 10.1.1.1 Asia Pacific Dermal Fillers Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.2 China: Asia Pacific Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.1.2.1 China: Asia Pacific Dermal Fillers Market Breakdown, by Product
    - 10.1.1.2.2 China: Asia Pacific Dermal Fillers Market Breakdown, by Material
    - 10.1.1.2.3 China: Asia Pacific Dermal Fillers Market Breakdown, by Application
    - 10.1.1.2.4 China: Asia Pacific Dermal Fillers Market Breakdown, by End User
  - 10.1.1.3 Japan: Asia Pacific Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.1.3.1 Japan: Asia Pacific Dermal Fillers Market Breakdown, by Product
    - 10.1.1.3.2 Japan: Asia Pacific Dermal Fillers Market Breakdown, by Material
    - 10.1.1.3.3 Japan: Asia Pacific Dermal Fillers Market Breakdown, by Application
    - 10.1.1.3.4 Japan: Asia Pacific Dermal Fillers Market Breakdown, by End User
  - 10.1.1.4 India: Asia Pacific Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.1.4.1 India: Asia Pacific Dermal Fillers Market Breakdown, by Product
    - 10.1.1.4.2 India: Asia Pacific Dermal Fillers Market Breakdown, by Material
    - 10.1.1.4.3 India: Asia Pacific Dermal Fillers Market Breakdown, by Application
    - 10.1.1.4.4 India: Asia Pacific Dermal Fillers Market Breakdown, by End User
  - 10.1.1.5 Australia: Asia Pacific Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.1.5.1 Australia: Asia Pacific Dermal Fillers Market Breakdown, by Product
    - 10.1.1.5.2 Australia: Asia Pacific Dermal Fillers Market Breakdown, by Material
    - 10.1.1.5.3 Australia: Asia Pacific Dermal Fillers Market Breakdown, by Application
    - 10.1.1.5.4 Australia: Asia Pacific Dermal Fillers Market Breakdown, by End User
  - 10.1.1.6 South Korea: Asia Pacific Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.1.6.1 South Korea: Asia Pacific Dermal Fillers Market Breakdown, by Product
    - 10.1.1.6.2 South Korea: Asia Pacific Dermal Fillers Market Breakdown, by Material
    - 10.1.1.6.3 South Korea: Asia Pacific Dermal Fillers Market Breakdown, by Application
    - 10.1.1.6.4 South Korea: Asia Pacific Dermal Fillers Market Breakdown, by End User
  - 10.1.1.7 Rest of Asia Pacific: Asia Pacific Dermal Fillers Market - Revenue and Forecast to 2031 (US$ Million)
    - 10.1.1.7.1 Rest of Asia Pacific: Asia Pacific Dermal Fillers Market Breakdown, by Product
    - 10.1.1.7.2 Rest of Asia Pacific: Asia Pacific Dermal Fillers Market Breakdown, by Material
    - 10.1.1.7.3 Rest of Asia Pacific: Asia Pacific Dermal Fillers Market Breakdown, by Application
    - 10.1.1.7.4 Rest of Asia Pacific: Asia Pacific Dermal Fillers Market Breakdown, by End User

11. Dermal Fillers Market - Industry Landscape

11.1 Overview
11.2 Growth Strategies in Dermal Fillers Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Dermal Fillers Market - Competitive Landscape

12.1 Heat Map Analysis by Key Players
12.2 Company Positioning and Concentration - Company Share Analysis - 2022
12.3 Company Product Revenue

13. Company Profiles

13.1 AbbVie Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Galderma SA
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Merz Pharma GmbH & Co KGaA
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Suneva Medical
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 BIOXIS pharmaceuticals
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 BIOPLUS CO., LTD.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 TEOXANE LABORATORIES
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Prollenium Medical Technologies
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Sinclair Pharma Ltd
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments

14. Appendix

14.1 About The Insight Partners